Kristen Lawrence

Kristen Lawrence supports the procurement mission of the W4PZ USA Medical Research Acquisition Act under the Department of the Army, facilitating acquisitions that advance military biomedical innovation and warfighter health readiness. While her formal title is not specified, her work centers on managing research and development contracts for next-generation diagnostic, therapeutic, and analytical technologies. She handles complex, high-stakes procurements spanning biotechnology, clinical diagnostics, engineering services, and software development, ensuring that laboratory breakthroughs are translated into field-deployable medical capabilities for the U.S. military. Her role is pivotal in aligning acquisition strategy with the agency’s mission to accelerate innovation in life sciences and combat-relevant health solutions. Lawrence collaborates with a diverse ecosystem of contractors, including research institutions, biotech startups, engineering firms, and software publishers, all focused on defense-critical medical technologies. Though specific contractor names are not publicly identified, her procurement patterns suggest consistent engagement with entities capable of rapid prototyping, clinical validation, and ruggedized system integration. She fosters partnerships with vendors possessing deep technical expertise in molecular diagnostics, nanoscale sensing, and data-driven health analytics, emphasizing agility, scalability, and compliance with federal biomedical standards. Her contracting approach reflects a balanced commitment to socioeconomic goals, with approximately one-third of acquisitions set aside for total small businesses under FAR 19.5. While the majority of awards are open competition, her consistent use of small business set-asides demonstrates a deliberate effort to cultivate innovation from emerging firms and foster a competitive vendor base. She does not appear to prioritize 8(a), HUBZone, or SDVOSB set-asides exclusively, but rather leverages broad small business eligibility to maximize innovation capacity. Lawrence’s primary NAICS focus includes research and development in biotechnology and nanotechnology, engineering services, and software publishing—all critical to modern military medicine. She procures advanced diagnostic tools, point-of-care analytics platforms, biomedical sensors, and computational health models, reflecting deep technical expertise in translational research and defense-relevant life sciences. Her portfolio underscores a strategic emphasis on dual-use technologies that enhance both battlefield readiness and broader medical capability.